Direct Synthesis of α- and β-2'-Deoxynucleosides with Stereodirecting Phosphine Oxide via Remote Participation
2'-Deoxynucleosides and analogues play a vital role in drug development, but their preparation remains a significant challenge. Previous studies have focused on β-2'-deoxynucleosides with the natural β-configuration. In fact, their isomeric α-2'-deoxynucleosides also exhibit diverse bioactivities and even better metabolic stability. Herein, we report that both α- and β-2'-deoxynucleosides can be prepared with high yields and stereoselectivity using a remote directing diphenylphosphinoyl (DPP) group. It is particularly efficient to prepare α-2'-deoxynucleosides with an easily accessible 3,5-di-ODPP donor. Instead of acting as a H-bond acceptor on a 2-(diphenylphosphinoyl)acetyl (DPPA) group in our previous studies for syn-facial O-glycosylation, the phosphine oxide moiety here acts as a remote participating group to enable highly antifacial N-glycosylation. This proposed remote participation mechanism is supported by our first characterization of an important 1,5-briged P-heterobicyclic intermediate via variable-temperature NMR spectroscopy. Interestingly, antiproliferative assays led to a α-2'-deoxynucleoside with IC50 values in the low micromole range against central nervous system tumor cell lines SH-SY5Y and LN229, whereas its β-anomer exhibited no inhibition at 100 μM. Furthermore, the DPP group significantly enhanced the antitumor activities by 10 times.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:146 |
---|---|
Enthalten in: |
Journal of the American Chemical Society - 146(2024), 12 vom: 27. März, Seite 8768-8779 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tang, Xintong [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 28.03.2024 Date Revised 28.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1021/jacs.4c01780 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369730208 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369730208 | ||
003 | DE-627 | ||
005 | 20240329000809.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240315s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1021/jacs.4c01780 |2 doi | |
028 | 5 | 2 | |a pubmed24n1353.xml |
035 | |a (DE-627)NLM369730208 | ||
035 | |a (NLM)38483318 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tang, Xintong |e verfasserin |4 aut | |
245 | 1 | 0 | |a Direct Synthesis of α- and β-2'-Deoxynucleosides with Stereodirecting Phosphine Oxide via Remote Participation |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.03.2024 | ||
500 | |a Date Revised 28.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a 2'-Deoxynucleosides and analogues play a vital role in drug development, but their preparation remains a significant challenge. Previous studies have focused on β-2'-deoxynucleosides with the natural β-configuration. In fact, their isomeric α-2'-deoxynucleosides also exhibit diverse bioactivities and even better metabolic stability. Herein, we report that both α- and β-2'-deoxynucleosides can be prepared with high yields and stereoselectivity using a remote directing diphenylphosphinoyl (DPP) group. It is particularly efficient to prepare α-2'-deoxynucleosides with an easily accessible 3,5-di-ODPP donor. Instead of acting as a H-bond acceptor on a 2-(diphenylphosphinoyl)acetyl (DPPA) group in our previous studies for syn-facial O-glycosylation, the phosphine oxide moiety here acts as a remote participating group to enable highly antifacial N-glycosylation. This proposed remote participation mechanism is supported by our first characterization of an important 1,5-briged P-heterobicyclic intermediate via variable-temperature NMR spectroscopy. Interestingly, antiproliferative assays led to a α-2'-deoxynucleoside with IC50 values in the low micromole range against central nervous system tumor cell lines SH-SY5Y and LN229, whereas its β-anomer exhibited no inhibition at 100 μM. Furthermore, the DPP group significantly enhanced the antitumor activities by 10 times | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a phosphine |2 NLM | |
650 | 7 | |a FW6947296I |2 NLM | |
650 | 7 | |a Phosphines |2 NLM | |
700 | 1 | |a Zhou, Yueer |e verfasserin |4 aut | |
700 | 1 | |a Wang, Yingjie |e verfasserin |4 aut | |
700 | 1 | |a Lin, Yetong |e verfasserin |4 aut | |
700 | 1 | |a Pan, Shuheng |e verfasserin |4 aut | |
700 | 1 | |a Che, Qianwei |e verfasserin |4 aut | |
700 | 1 | |a Sang, Jinpeng |e verfasserin |4 aut | |
700 | 1 | |a Gao, Ziming |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Weiting |e verfasserin |4 aut | |
700 | 1 | |a Wang, Yuanyuan |e verfasserin |4 aut | |
700 | 1 | |a Li, Guolong |e verfasserin |4 aut | |
700 | 1 | |a Gao, Longwei |e verfasserin |4 aut | |
700 | 1 | |a Wang, Zhimei |e verfasserin |4 aut | |
700 | 1 | |a Yang, Xudong |e verfasserin |4 aut | |
700 | 1 | |a Liu, Ao |e verfasserin |4 aut | |
700 | 1 | |a Wang, Suyu |e verfasserin |4 aut | |
700 | 1 | |a Yu, Biao |e verfasserin |4 aut | |
700 | 1 | |a Xu, Peng |e verfasserin |4 aut | |
700 | 1 | |a Wang, Zhe |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Zhaolun |e verfasserin |4 aut | |
700 | 1 | |a Yang, Peng |e verfasserin |4 aut | |
700 | 1 | |a Xie, Weijia |e verfasserin |4 aut | |
700 | 1 | |a Sun, Haopeng |e verfasserin |4 aut | |
700 | 1 | |a Li, Wei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the American Chemical Society |d 1945 |g 146(2024), 12 vom: 27. März, Seite 8768-8779 |w (DE-627)NLM00000569X |x 1520-5126 |7 nnns |
773 | 1 | 8 | |g volume:146 |g year:2024 |g number:12 |g day:27 |g month:03 |g pages:8768-8779 |
856 | 4 | 0 | |u http://dx.doi.org/10.1021/jacs.4c01780 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 146 |j 2024 |e 12 |b 27 |c 03 |h 8768-8779 |